Unfortunately, to date there are no studies investigating the differences in outcomes between prostate cancer patients treated with GnRH analogs followed by docetaxel vs. orchiectomy followed by the chemotherapeutic drug. The gene discussed is GNRH1; the disease is Familial prostate cancer.